My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 124

    1.

    Transformation of human osteoblast cells to the tumorigenic phenotype by depleted uranium-uranyl chloride.

    Miller AC, Blakely WF, Livengood D, Whittaker T, Xu J, Ejnik JW, Hamilton MM, Parlette E, John TS, Gerstenberg HM, Hsu H.

    Environ Health Perspect. 1998 Aug;106(8):465-71.PMID: 9681973 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Neoplastic transformation of human osteoblast cells to the tumorigenic phenotype by heavy metal-tungsten alloy particles: induction of genotoxic effects.

    Miller AC, Mog S, McKinney L, Luo L, Allen J, Xu J, Page N.

    Carcinogenesis. 2001 Jan;22(1):115-25.PMID: 11159749 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Suppression of depleted uranium-induced neoplastic transformation of human cells by the phenyl fatty acid, phenyl acetate: chemoprevention by targeting the p21RAS protein pathway.

    Miller AC, Xu J, Stewart M, McClain D.

    Radiat Res. 2001 Jan;155(1 Pt 2):163-170.PMID: 11121229 [PubMed - indexed for MEDLINE]Related articles

    4.

    Observation of radiation-specific damage in human cells exposed to depleted uranium: dicentric frequency and neoplastic transformation as endpoints.

    Miller AC, Xu J, Stewart M, Brooks K, Hodge S, Shi L, Page N, McClain D.

    Radiat Prot Dosimetry. 2002;99(1-4):275-8.PMID: 12194305 [PubMed - indexed for MEDLINE]Related articles

    5.

    Leukemic transformation of hematopoietic cells in mice internally exposed to depleted uranium.

    Miller AC, Bonait-Pellie C, Merlot RF, Michel J, Stewart M, Lison PD.

    Mol Cell Biochem. 2005 Nov;279(1-2):97-104.PMID: 16283518 [PubMed - indexed for MEDLINE]Related articles

    6.

    Potential late health effects of depleted uranium and tungsten used in armor-piercing munitions: comparison of neoplastic transformation and genotoxicity with the known carcinogen nickel.

    Miller AC, Xu J, Stewart M, Prasanna PG, Page N.

    Mil Med. 2002 Feb;167(2 Suppl):120-2.PMID: 11873492 [PubMed - indexed for MEDLINE]Related articles

    7.

    Transformation of immortal, non-tumorigenic osteoblast-like human osteosarcoma cells to the tumorigenic phenotype by nickel sulfate.

    Rani AS, Qu DQ, Sidhu MK, Panagakos F, Shah V, Klein KM, Brown N, Pathak S, Kumar S.

    Carcinogenesis. 1993 May;14(5):947-53.PMID: 8504488 [PubMed - indexed for MEDLINE]Related articles

    8.

    Effect of the militarily-relevant heavy metals, depleted uranium and heavy metal tungsten-alloy on gene expression in human liver carcinoma cells (HepG2).

    Miller AC, Brooks K, Smith J, Page N.

    Mol Cell Biochem. 2004 Jan;255(1-2):247-56.PMID: 14971665 [PubMed - indexed for MEDLINE]Related articles

    9.

    [Malignant transformation of human bronchial epithelial cell (BEAS-2B) induced by depleted uranium]

    Yang ZH, Fan BX, Lu Y, Cao ZS, Yu S, Fan FY, Zhu MX.

    Ai Zheng. 2002 Sep;21(9):944-8. Chinese. PMID: 12508538 [PubMed - indexed for MEDLINE]Related articles

    10.

    Transformation of human osteoblasts to anchorage-independent growth by insoluble nickel particles.

    Lin X, Costa M.

    Environ Health Perspect. 1994 Sep;102 Suppl 3:289-92.PMID: 7843117 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Morphological and neoplastic transformation of C3H/10T1/2 Cl 8 mouse embryo cells by insoluble carcinogenic nickel compounds.

    Miura T, Patierno SR, Sakuramoto T, Landolph JR.

    Environ Mol Mutagen. 1989;14(2):65-78.PMID: 2548861 [PubMed - indexed for MEDLINE]Related articles

    12.

    Genomic instability in human osteoblast cells after exposure to depleted uranium: delayed lethality and micronuclei formation.

    Miller AC, Brooks K, Stewart M, Anderson B, Shi L, McClain D, Page N.

    J Environ Radioact. 2003;64(2-3):247-59.PMID: 12500809 [PubMed - indexed for MEDLINE]Related articles

    13.

    Surveillance of depleted uranium exposed Gulf War veterans: health effects observed in an enlarged "friendly fire" cohort.

    McDiarmid MA, Squibb K, Engelhardt S, Oliver M, Gucer P, Wilson PD, Kane R, Kabat M, Kaup B, Anderson L, Hoover D, Brown L, Jacobson-Kram D; Depleted Uranium Follow-Up Program.

    J Occup Environ Med. 2001 Dec;43(12):991-1000.PMID: 11765683 [PubMed - indexed for MEDLINE]Related articles

    14.

    Depleted uranium-catalyzed oxidative DNA damage: absence of significant alpha particle decay.

    Miller AC, Stewart M, Brooks K, Shi L, Page N.

    J Inorg Biochem. 2002 Jul 25;91(1):246-52.PMID: 12121782 [PubMed - indexed for MEDLINE]Related articles

    15.

    A review of the effects of uranium and depleted uranium exposure on reproduction and fetal development.

    Arfsten DP, Still KR, Ritchie GD.

    Toxicol Ind Health. 2001 Jun;17(5-10):180-91. Review.PMID: 12539863 [PubMed - indexed for MEDLINE]Related articles

    16.

    Biological effects of embedded depleted uranium (DU): summary of armed forces radiobiology research institute research.

    McClain DE, Benson KA, Dalton TK, Ejnik J, Emond CA, Hodge SJ, Kalinich JF, Landauer MA, Miller AC, Pellmar TC, Stewart MD, Villa V, Xu J.

    Sci Total Environ. 2001 Jul 2;274(1-3):115-8.PMID: 11453287 [PubMed - indexed for MEDLINE]Related articles

    17.

    Toxicology and Carcinogenesis Studies of 5,5-Diphenylhydantoin (CAS No. 57-41-0) (Phenytoin) in F344/N Rats and B6C3F1 Mice (Feed Studies).

    National Toxicology Program.

    Natl Toxicol Program Tech Rep Ser. 1993 Nov;404:1-303.PMID: 12621514 [PubMed - as supplied by publisher]Related articlesFree article

    18.

    Health effects of embedded depleted uranium.

    McClain DE, Benson KA, Dalton TK, Ejnik J, Emond CA, Hodge SJ, Kalinich JF, Landauer MR, Livengood DR, Miller AC, Pellmar TC, Stewart MD, Villa V, Xu J.

    Mil Med. 2002 Feb;167(2 Suppl):117-9.PMID: 11873491 [PubMed - indexed for MEDLINE]Related articles

    19.

    Tumor apoptosis induced by epoxide-containing piperazines, a new class of anti-cancer agents.

    Eilon GF, Gu J, Slater LM, Hara K, Jacobs JW.

    Cancer Chemother Pharmacol. 2000;45(3):183-91.PMID: 10663635 [PubMed - indexed for MEDLINE]Related articles

    20.

    NTP Toxicology and Carcinogenesis Studies of Oxazepam (CAS No. 604-75-1) in Swiss-Webster and B6C3F1 Mice (Feed Studies).

    National Toxicology Program.

    Natl Toxicol Program Tech Rep Ser. 1993 Aug;443:1-321.PMID: 12595920 [PubMed - as supplied by publisher]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity